Financing
Proceeds from Commercial Paper and Secured Lines of Credit
Elevance Health Proceeds from Commercial Paper and Secured Lines of Credit increased by 40.6% to $724.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2013
Last reportedQ1 2026Apr 22, 2026
Metric ID:
schw_proceeds_from_cp_and_secured_linesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $175.00M | $0.00 | $1.20B | $90.00M | $325.00M | -$325.00M | $0.00 | $225.00M | $1.35B | $65.00M | $0.00 | $515.00M | $724.00M |
| QoQ Change | — | -100.0% | — | -92.5% | +261.1% | -200.0% | +100.0% | — | +500.0% | -95.2% | -100.0% | — | +40.6% |
| YoY Change | — | — | — | — | — | — | -100.0% | — | +315.4% | -71.1% | -100.0% | +692.3% | — |
Range-$325.00M – $1.35B
CAGR+60.5%
Avg YoY Growth+147.3%
Median YoY Growth-71.1%
Current Streak2 quarters growth
Proceeds from Commercial Paper and Secured Lines of Credit at Other Companies
Frequently Asked Questions
- What is Elevance Health's proceeds from commercial paper and secured lines of credit?
- Elevance Health (ELV) reported proceeds from commercial paper and secured lines of credit of $724.00M in Q1 2026.